DNA Vaccine
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
40
NCT06831812
Phase I Clinical Study of AV-1959R: Abeta-targeting Anti-Alzheimer's Vaccine
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 12, 2024
Completion: Oct 31, 2025
NCT07142278
DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau
Start: Nov 1, 2025
Completion: Jul 31, 2027
Loading map...